Group b streptococcus identification and drug susceptibility testing card, group b streptococcus identification and drug susceptibility testing kit and methods of using the same

A detection kit and sensitive detection card technology, applied in the field of biomedicine, can solve the problems of difficulty in meeting the needs of hospitals, poor sensitivity and specificity, and long time consumption, so as to improve the convenience of sample addition, the convenience of the sample addition process, and the detection cost. low effect
CN107299127BActive Publication Date: 2020-11-06广东阳光生物科技有限公司
6 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
广东阳光生物科技有限公司
Publication Date
2020-11-06

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses an identification and drug sensitivity test card for group B streptococcus, an identification and drug sensitivity test kit for the group B streptococcus and a using method of the identification and drug sensitivity test kit for the group B streptococcus. The identification and drug sensitivity test card for the group B streptococcus comprises a test card body, wherein an identification micropore area and a drug sensitivity test area are arranged on the test card body; the identification micropore area is provided with a plurality of identification micropores; the drug sensitivity test area is provided with a plurality of drug sensitivity micropores. According to the identification and drug sensitivity test card for the group B streptococcus disclosed by the invention, an identification experiment and a drug sensitivity test experiment on the group B streptococcus can be carried out at the same time, and the convenience is better. Based on a display method / a turbidimetric method, identification and drug sensitivity experiments on the group B streptococcus are carried out; compared with nucleic acid test, the test cost is lower.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the technical field of biomedicine, in particular to a group B streptococcus identification and drug sensitivity detection card, a group B streptococcus identification and drug sensitivity detection kit and a use method thereof. Background technique

[0002] Group B streptococcus (GBS), also known as S. agalactiae, was first discovered in 1938. In 1938, Fry first reported three cases of postpartum endocarditis caused by group B streptococcus infection. Death, confirming that group B streptococci are pathogenic bacteria in humans. After the development of science and technology, it was found that group B streptococcus can cause neonatal sepsis, pneumonia, meningitis, and even death. Neonates who survive infection may also have severe neurological sequelae, including hydrocephalus, intellectual disability, microcephaly, and deafness. At the same time, Group B Streptococcus can also cause infection in pregnant women, premature d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More